Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Molnar-Kimber

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Transplantation|May 1, 1981
Evidence that strong Mls determinants are nonpolymorphicK L Molnar-Kimber, J Sprent
Journal of Virology|July 1, 1984
Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcriptionK L Molnar-Kimber, J W Summers, W S Mason
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1980
T cell lines with dual specificity for strong Mls and H-2 determinantsK L Molnar-Kimber, S R Webb, J Sprent, et al.
Mediators of Inflammation|January 1, 1992
Differential regulation of TNF-alpha and IL-1beta production from endotoxin stimulated human monocytes by phosphodiesterase inhibitorsK L Molnar-Kimber, L Yonno, R J Heaslip, et al.
Journal of Virology|January 1, 1983
Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virusK L Molnar-Kimber, J Summers, J M Taylor, et al.
International Journal of Immunopharmacology|April 1, 1992
Strategies for the development of new antiarthritic agentsA J Lewis, K B Glaser, R J Sturm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancerG Coukos, A Makrigiannakis, E H Kang, et al.
Human Gene Therapy|December 28, 1999
Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancerT Toyoizumi, R Mick, A E Abbas, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1983
Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virusM S Halpern, J M England, D T Deery, et al.
The Annals of Thoracic Surgery|December 10, 1999
Oncolytic therapy using a mutant type-1 herpes simplex virus and the role of the immune systemE S Lambright, D J Caparrelli, A E Abbas, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Transplantation|May 1, 1981
Evidence that strong Mls determinants are nonpolymorphicK L Molnar-Kimber, J Sprent
Journal of Virology|July 1, 1984
Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcriptionK L Molnar-Kimber, J W Summers, W S Mason
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1980
T cell lines with dual specificity for strong Mls and H-2 determinantsK L Molnar-Kimber, S R Webb, J Sprent, et al.
Mediators of Inflammation|January 1, 1992
Differential regulation of TNF-alpha and IL-1beta production from endotoxin stimulated human monocytes by phosphodiesterase inhibitorsK L Molnar-Kimber, L Yonno, R J Heaslip, et al.
Journal of Virology|January 1, 1983
Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virusK L Molnar-Kimber, J Summers, J M Taylor, et al.
International Journal of Immunopharmacology|April 1, 1992
Strategies for the development of new antiarthritic agentsA J Lewis, K B Glaser, R J Sturm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancerG Coukos, A Makrigiannakis, E H Kang, et al.
Human Gene Therapy|December 28, 1999
Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancerT Toyoizumi, R Mick, A E Abbas, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1983
Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virusM S Halpern, J M England, D T Deery, et al.
The Annals of Thoracic Surgery|December 10, 1999
Oncolytic therapy using a mutant type-1 herpes simplex virus and the role of the immune systemE S Lambright, D J Caparrelli, A E Abbas, et al.
Pageof 3